Select a medication above to begin.
Symlin
pramlintide
Black Box Warnings .
Severe Hypoglycemia
use w/ insulin incr. risk of severe hypoglycemia, particularly in type 1 DM; may occur w/in 3h of pramlintide inj; serious injury may occur while operating motor vehicle/heavy machinery or during high-risk activity; decr. risk w/ appropriate pt selection, pt instruction, and insulin dose reduction
Adult Dosing .
Dosage forms: INJ (SymlinPen 60 pen): 1500 mcg per 1.5 mL; INJ (SymlinPen 120 pen): 2700 mcg per 2.7 mL
Special Note
- [prescribing info]
- Info: use SymlinPen 60 pen for 15 mcg, 30 mcg, 45 mcg, 60 mcg doses; use SymlinPen 120 pen for 60 mcg, 120 mcg doses
diabetes mellitus, type 1
- [30-60 mcg SC qac]
- Start: 15 mcg SC qac, then may incr. by 15 mcg/dose no more frequently than q3 days
diabetes mellitus, type 2
- [120 mcg SC qac]
- Start: 60 mcg SC qac x3 days, then may incr. to 120 mcg SC qac; Info: use w/ insulin
renal dosing
- [see below]
- CrCl >15: no adjustment; CrCl <15 or ESRD: not defined
- HD/PD: not defined
hepatic dosing
- [no adjustment]
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.